AstraZeneca prices $3bn, three-tranche bond offering
4th Aug 2020 11:11
(Sharecast News) - AstraZeneca has priced a three-tranche global bond offering totalling $3bn (£2.3bn), it announced on Tuesday, to possibly repay its current debt.
Read moreRedx Pharma surges on AstraZeneca licensing agreement
4th Aug 2020 08:45
(Sharecast News) - Redx Pharma shares soared on Tuesday after it signed a licensing agreement with AstraZeneca for its porcupine inhibitor for fibrotic diseases, RXC006.
Read moreWHO warns 'silver bullet' for Covid-19 may never come
3rd Aug 2020 13:01
(Sharecast News) - The World Health Organization warned on Monday that there is a possibility that a "silver bullet" to combat Covid-19 may never come despite the existing strong hopes for a vaccine.
Read moreEurope midday: Losses accelerate as investors fret over epidemic's path
30th Jul 2020 10:44
(Sharecast News) - Losses in stockmarkets across Europe accelerated as investors digested data showing that German gross domestic product fell at its quickest pace on record since at least 1970.
Read moreAstraZeneca maintains guidance after first-half growth
30th Jul 2020 07:27
(Sharecast News) - AstraZeneca reported a 12% rise in total revenue in its first half on Thursday, or 14% at constant exchange rates, to $12.63bn (£9.75bn), with growth across all three of its therapy areas and in all of its regions.
Read moreThursday preview: US tech titans, AstraZeneca in focus
29th Jul 2020 16:19
(Sharecast News) - The market spotlight will fall on earnings reports from several of the largest corporates in the States, as they update shareholders on their performance over the three months to June, including Amazon, Alphabet, Facebook, and Microsoft.
Read moreWednesday broker round-up
29th Jul 2020 13:29
(Sharecast News) - Sanne: RBC Capital Markets reiterates sector performer with a target price of 600.0p.
Read moreAstraZeneca upbeat on latest Farxiga trial results
28th Jul 2020 08:38
(Sharecast News) - AstraZeneca said on Tuesday that high-level results from the phase 3 'DAPA-CKD- trial of 'Farxiga', or dapagliflozin, showed a "statistically significant and clinically meaningful" effect on its primary endpoint.
Read moreModerna starts dosing patients for phase III Covid-19 vaccine clinical trial
27th Jul 2020 12:29
(Sharecast News) - Moderna has started to dose patients in its 30,000-strong phase three clinical trial of its Covid-19 vaccine candidate, mRNA-1273.
Read moreAstraZeneca gets two EMA recommendations, enters oncology partnership
27th Jul 2020 08:16
(Sharecast News) - AstraZeneca shareholders were met with a raft of updates from the company on Monday morning, including two positive recommendations from the European Medicines Agency, and the announcement of a new oncology collaboration.
Read moreIsraeli researchers believe treatment might sharply reduce Covid-19 symptoms
27th Jul 2020 08:05
(Sharecast News) - Israeli researchers have claimed that an off-the-shelf treatment may possibly reduce the symptoms from Covid-19 to those of the common cold.
Read moreAstraZeneca gets approval for COPD treatment in US
24th Jul 2020 07:27
(Sharecast News) - AstraZeneca announced on Friday that 'Breztri Aerosphere', or budesonide, glycopyrrolate and formoterol fumarate, has been approved in the United States for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Read moreOxford University's Gilbert says vaccine rollout possible by Xmas, but not certain
21st Jul 2020 15:09
(Sharecast News) - The lead researcher in Oxford University's push to find a Covid-19 vaccine alongside AstraZeneca cautioned on Tuesday that there could be no certainty that it could be rolled out by Christmas - although it was possible.
Read moreJP Morgan stay 'overweight' on AstraZeneca despite 'aggressive' rise in shares
21st Jul 2020 13:51
(Sharecast News) - JP Morgan analysts reiterated their 'overweight' stance and 9,500.0p target price on shares of AstraZeneca following the release of early clinical trial data for its Covid-19 vaccine candidate, AZD1222, the day before.
Read moreTuesday broker round-up
21st Jul 2020 12:58
(Sharecast News) - Premier Oil: Peel Hunt upgrades to buy with a target price of 50.0p.
Read more